Monrovia, CA -- (SBWire) -- 04/18/2012 --GTC’s Life Science Legal & Business Strategy Conference is the only biotech regulatory conference on the west coast. Providing executive level insight into the legal issues of greatest concern in today’s business environment, the conference also offers in depth knowledge and perspectives into the latest regulatory changes and how to develop plans to protect your organization and its products as well as prepare for opportunities that may only exist for a limited time.

MCLE Credit of 11.5 hours approved by the California State Bar.

The law firm of Mayer Brown is sponsoring this timely conference and will offer the event’s opening presentation. Mayer Brown was recently named as a 2012 finalist for the prestigious “Litigation Department of the Year” by The American Lawyer magazine.

Topics to be discussed during the Conference include:
- America Invents Act
- FDA regulation and enforcement
- User fee legislation
- Outsourcing drug development
- Satisfying safety reporting standards
- Ensuring clinical trial compliance
- Hatch-Waxman legislation
- Trade secret protections
- Pharmaceutical anti-counterfeiting
- Advertising regulations impacting biotech
- Social media standards
-Intellectual property protection
- Compliance standards of non-FDA agencies
- False Claims Act

About GTC
Specializing in the healthcare industries, GTC develops independent events bringing together executive level professionals to acquire the latest industry data while networking and building important business relationships. You may visit GTC at www.gtcinsight.com.